Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
HR negative + BRCA2 mutation
i
Other names:
BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset, ER (Estrogen receptor), PGR (Progesterone receptor)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2099
;
5241
;
675
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
ER-CCDC170 fusion (3)
BRCA2 fusion (0)
ER-CCDC170 fusion (3)
BRCA2 fusion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
HR negative + BRCA2 mutation
HER2 Negative Breast Cancer
HR negative + BRCA2 mutation
HER2 Negative Breast Cancer
olaparib
Sensitive: A2 - Guideline
olaparib
Sensitive
:
A2
olaparib
Sensitive: A2 - Guideline
olaparib
Sensitive
:
A2
HR negative + BRCA2 mutation
HER2 Negative Breast Cancer
HR negative + BRCA2 mutation
HER2 Negative Breast Cancer
carboplatin + paclitaxel
Sensitive: C3 – Early Trials
carboplatin + paclitaxel
Sensitive
:
C3
carboplatin + paclitaxel
Sensitive: C3 – Early Trials
carboplatin + paclitaxel
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.